Assignment of RSV Antibody Patents. Effective as of such termination, Arsanis shall, and it hereby does, assign to Adimab all right, title and interest in and to all RSV Antibody Patents;
Appears in 4 contracts
Sources: Option and License Agreement, Option and License Agreement (Arsanis, Inc.), Option and License Agreement (Arsanis, Inc.)